Microbix Biosystems (TSE:MBX) Stock Crosses Above Fifty Day Moving Average – Here’s Why

Shares of Microbix Biosystems Inc. (TSE:MBX) crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of C$0.23 and traded as high as C$0.24. Microbix Biosystems shares last traded at C$0.24, with a volume of 9,400 shares.

Microbix Biosystems Price Performance

The company has a current ratio of 7.51, a quick ratio of 5.57 and a debt-to-equity ratio of 30.47. The company has a 50-day simple moving average of C$0.23 and a 200 day simple moving average of C$0.24. The company has a market cap of C$31.17 million, a P/E ratio of -7.50 and a beta of 0.40.

Microbix Biosystems (TSE:MBX) last released its earnings results on Thursday, February 12th. The company reported C($0.01) earnings per share for the quarter. The business had revenue of C$4.22 million for the quarter. Microbix Biosystems had a negative return on equity of 14.88% and a negative net margin of 25.48%. On average, equities analysts anticipate that Microbix Biosystems Inc. will post 0.02 EPS for the current year.

About Microbix Biosystems

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.